Psychological and cognitive effects of long-term peyote use among Native Americans.
John H. Halpern, Andrea R Sherwood, James I. Hudson, Deborah A Yurgelun-Todd, Harrison G. Pope
Biological Psychiatry October 15, 2005 DOI: 10.1016/j.biopsych.2005.06.038 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Sample size | 176 |
| Population | Navajo Native Americans aged 18-45 |
| Topics | Mescaline |
| Citations | 186 |
| Key findings | Regular peyote use in a religious setting was not associated with psychological or cognitive deficits, while past alcohol dependence was. |
Abstract
Hallucinogens are widely used, both by drug abusers and by peoples of traditional cultures who ingest these substances for religious or healing purposes. However, the long-term residual psychological and cognitive effects of hallucinogens remain poorly understood. We recruited three groups of Navajo Native Americans, age 18-45: 1) 61 Native American Church members who regularly ingested peyote, a hallucinogen-containing cactus; 2) 36 individuals with past alcohol dependence, but currently sober at least 2 months; and 3) 79 individuals reporting minimal use of peyote, alcohol, or other substances. We administered a screening interview, the Rand Mental Health Inventory (RMHI), and ten standard neuropsychological tests of memory and attentional/executive functions. Compared to Navajos with minimal substance use, the peyote group showed no significant deficits on the RMHI or any neuropsychological measures, whereas the former alcoholic group showed significant deficits (p < .05) on every scale of the RMHI and on two neuropsychological measures. Within the peyote group, total lifetime peyote use was not significantly associated with neuropsychological performance. We found no evidence of psychological or cognitive deficits among Native Americans using peyote regularly in a religious setting. It should be recognized, however, that these findings may not generalize to illicit hallucinogen users.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
State of the evidence: Mescaline No effect
Regular ceremonial peyote use showed no significant psychological or cognitive deficits, and lifetime peyote use was not associated with neuropsychological performance.
Synthesized
Comparable studies
Other observational and cohort studies on mescaline, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psychedelics not linked to mental health problems or suicidal behavior: A population study Randomly selected United States adults | 2015 | Observational cohort | n = 135,095 |
| Long-lasting subjective effects of LSD in normal subjects Healthy participants | 2017 | Observational cohort | n = 16 |
| Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: experimental psychosis as a tool for psychiatric research. Normal men who were volunteers | 1992 | Observational cohort | n = 12 |
| 2,5-Dimethoxy-4-methyl-amphetamine (STP): A New Hallucinogenic Drug Normal control volunteers | 1967 | Observational study | |
| EFFECTS OF MESCALINE AND LYSERGIC ACID (d-LSD-25) Schizophrenic patients and normal individuals | 1952 | Observational study |
Citations in the library
Cited by 106
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacology & Therapeutics May 1, 2019
- Psychedelics and Mental Health: A Population Study PLoS One August 19, 2013
- Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada Current Drug Abuse Reviews June 1, 2013
- Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. Journal of Psychopharmacology February 2, 2022
and 101 more in the library
Cites 12
- Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research Human Psychopharmacology: Clinical and Experimental December 1, 2001
- Peyote in the Treatment of Alcoholism Among American Indians American Journal of Psychiatry November 1, 1974
- Navajo Peyote Use: Its Apparent Safety American Journal of Psychiatry December 1, 1971
- Development of novel medications for drug addiction. The legacy of an African shrub. Annals of the New York Academy of Sciences 2000
- The Use of Hallucinogens in the Treatment of Addiction Addiction Research & Theory 1996
and 7 more in the library